NextCure Inc.
NXTC | NASDAQ
$5.71
-$0.60 (-9.51%)
Nov 2, 2026, 11:25 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 283K | 283K | n/a | n/a | n/a | 701K | 701K | 701K | 701K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -283K | -283K | n/a | n/a | n/a | -701K | -701K | -701K | -701K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -43.9M | -56.1M | -57.62M | -60.31M | -63.86M | -53.07M | -59.75M | -63.08M | -66.21M | -68.87M | -67.64M | -69.62M | -73.24M | -72.21M | -75.91M | -75.21M | -74.48M | -74.3M | -70.77M | -69.93M | -68.82M | -66.67M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M | -49.52M | -55.65M | -58.52M | -61.28M | -63.73M | -62.72M | -65.56M | -70.17M | -70.23M | -74.73M | -74.37M | -73.39M | -73.46M | -69.39M | -67.91M | -66.35M | -62.87M |
Net Income | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M | -49.52M | -55.65M | -58.52M | -61.28M | -63.73M | -62.72M | -65.56M | -70.17M | -70.23M | -74.73M | -74.37M | -73.39M | -73.46M | -69.39M | -67.91M | -66.35M | -62.87M |
Selling & General & Admin | 11.63M | 12.24M | 12.69M | 13.29M | 14.21M | 14.38M | 15.02M | 15.43M | 16.31M | 18.65M | 19.71M | 20.69M | 21.8M | 21.39M | 21.71M | 21.57M | 20.77M | 21.47M | 20.57M | 19.9M | 19.65M | 18.31M |
Research & Development | 27.2M | 43.86M | 44.92M | 47.03M | 49.66M | 37.99M | 41.49M | 44.41M | 46.65M | 47.68M | 47.93M | 48.93M | 51.44M | 50.82M | 54.2M | 53.64M | 53.71M | 52.83M | 50.19M | 50.03M | 49.18M | 48.36M |
Other Expenses | 4.79M | -283K | n/a | n/a | n/a | n/a | 2.54M | 2.54M | 2.54M | 2.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 43.62M | 55.82M | 57.62M | 60.31M | 63.86M | 52.37M | 59.05M | 62.38M | 65.51M | 68.87M | 67.64M | 69.62M | 73.24M | 72.21M | 75.91M | 75.21M | 74.48M | 74.3M | 70.77M | 69.93M | 68.82M | 66.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -701K | -701K | -701K | -701K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 43.9M | 56.1M | 57.62M | 60.31M | 63.86M | 53.07M | 59.75M | 63.08M | 66.21M | 68.87M | 67.64M | 69.62M | 73.24M | 72.21M | 75.91M | 75.21M | 74.48M | 74.3M | 70.77M | 69.93M | 68.82M | 66.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.31M | 5.24M | 3.51M | 2.68M | 2.37M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.32M | 2.32M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.3M | 2.3M | 2.3M | 2.3M |
Shares Outstanding (Diluted) | 5.31M | 5.24M | 3.51M | 2.68M | 2.37M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.32M | 2.32M | 2.31M | 2.31M | 2.31M | 2.31M | 2.31M | 2.3M | 2.3M | 2.3M | 2.3M |
EPS (Basic) | -10.58 | -19.07 | -21.90 | -24.18 | -25.91 | -21.23 | -23.89 | -25.14 | -26.35 | -27.44 | -27.04 | -28.29 | -30.31 | -30.36 | -32.33 | -32.20 | -31.82 | -31.88 | -30.15 | -29.53 | -28.87 | -27.37 |
EPS (Diluted) | -10.58 | -19.07 | -21.90 | -24.18 | -25.91 | -21.23 | -23.89 | -25.14 | -26.35 | -27.44 | -27.04 | -28.29 | -30.31 | -30.36 | -32.33 | -32.20 | -31.82 | -31.88 | -30.15 | -29.53 | -28.87 | -27.37 |
EBITDA | -41.57M | -52.85M | -53.66M | -55.52M | -58.27M | -46.79M | -51.44M | -54.16M | -56.67M | -58.88M | -59.04M | -61.69M | -66.22M | -66.2M | -70.61M | -69.15M | -67.45M | -68.27M | -64.85M | -65.26M | -65.59M | -62.9M |
EBIT | -42.75M | -54.66M | -55.84M | -58.01M | -60.93M | -49.52M | -54.31M | -57.17M | -59.93M | -62.39M | -62.72M | -65.56M | -70.17M | -70.23M | -74.73M | -74.37M | -73.39M | -73.46M | -70.09M | -69.39M | -68.86M | -66.67M |
Depreciation & Amortization | 1.18M | 1.81M | 2.19M | 2.49M | 2.66M | 2.73M | 2.87M | 3.02M | 3.26M | 3.51M | 3.68M | 3.87M | 3.94M | 4.03M | 4.12M | 5.22M | 5.94M | 5.19M | 5.24M | 4.13M | 3.27M | 3.77M |
Add to Watchlist
Select watchlists to add or remove NXTC